Explore News
-
AstraZeneca’s New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar
AstraZeneca’s elecoglipron shows promising results in phase 2 trial
-
AstraZeneca’s New Weight-Loss Pill Reveals Promising Trial Results
AstraZeneca’s new weight-loss pill has shown promising results in trials
-
Why AstraZeneca is Investing £300m in UK Pharma
AstraZeneca pledges £300m investment in UK pharma sector
